BUCHAREST (Romania), November 19 (SeeNews) – Romania's competition regulator said on Thursday it has launched an investigation into suspected unfair competition resulting from the acquisition by U.S. private equity fund Advent of some of the local assets of British pharmaceuticals company Ozone Laboratories.